McDonald Douglas C, Radakrishnan Sharmini, Sparks Alicia C, Corry Nida H, Carballo Carlos E, Carlson Kenneth, Stander Valerie A
Abt Associates, 6130 Executive Boulevard, Rockville, MD, 20852.
Leidos, 11951 Freedom Dr., Reston, VA 20190.
Mil Med. 2020 Sep 18;185(9-10):e1759-e1769. doi: 10.1093/milmed/usaa146.
The use and misuse of opioids by active service members has been examined in several studies, but little is known about their spouses' opioid use. This study estimates the number of military spouses who received high-risk or long-term opioid prescriptions between 2010 and 2014, and addresses how the Military Health System can help prevent risky prescribing in order to improve military force readiness.
This study used data from the Millennium Cohort Family Study, a nationwide survey of 9,872 spouses of service members with 2 to 5 years of military service, augmented with information from the military's Pharmacy Data Transaction Service about prescriptions for controlled drugs dispensed to these service members' spouses. Our objectives were to estimate the prevalence of opioid prescribing indicative of long-term use (≥60 day supply or at least one extended-release opioid prescription in any 3-month period) and, separately, high-risk use (daily dosage of ≥90 morphine mg equivalent or total dosage of ≥8,190 morphine mg equivalent, or prescriptions from more than three pharmacies, or concurrent prescriptions). For each of these dependent variables, we conducted bivariate analyses and multiple logistic regression models using information about spouses' physical health, sociodemographic characteristics, substance use behaviors, perceived social support, and stresses associated with military stress, among others. Informed consent, including consent to link survey responses to medical and personnel records, was obtained from all participants. The Naval Health Research Center's Institutional Review Board and the Office of Management and Budget approved the study.
Spouses were predominantly female (86%), had not served in the military themselves (79%), and were spouses of enlisted (91%) active duty (86%) service members. Almost half (47.6%) of spouses obtained at least one opioid prescription during the 2-year observation window, and 8.5% had received opioid prescriptions that posed risk to their health. About 7% met the criteria for receipt of high-risk opioid prescriptions, 3% obtained opioids from three or more pharmacies during a 3-month period, and 4% of spouses who received any opioids received both long-term and high-risk prescriptions. Adverse childhood experiences, physical pain, and lack of social support were associated with increased odds of obtaining high-risk opioid prescriptions.
Approximately 48% of military spouses had used Military Health System insurance to fill at least one opioid prescription during the 2-year observation period. The Department of Defense has taken measures to minimize high-risk opioid prescribing, including passing prescribing guidelines in 2017, establishing the controlled drug management analysis reporting tool, establishing a pain management education and training program, and more. These efforts should continue to expand as reducing the numbers of service members and spouses at risk for adverse events may be effective in reducing opioid misuse and improve the overall health and safety of military spouses and thus, the readiness of the U.S. Armed Forces.
多项研究对现役军人使用和滥用阿片类药物的情况进行了调查,但对其配偶使用阿片类药物的情况却知之甚少。本研究估算了2010年至2014年间接受高风险或长期阿片类药物处方的军属人数,并探讨军事卫生系统如何帮助预防危险处方,以提高军队战斗力。
本研究使用了千年队列家庭研究的数据,该研究是一项对9872名服役2至5年军人的配偶进行的全国性调查,并补充了军事药房数据交易服务中有关这些军人配偶所配发的管制药物处方的信息。我们的目标是估算表明长期使用(≥60天供应量或在任何3个月期间至少有一张缓释阿片类药物处方)以及分别估算高风险使用(每日剂量≥90毫克吗啡当量或总剂量≥8190毫克吗啡当量,或来自三个以上药房的处方,或同时开具的处方)的阿片类药物处方的患病率。对于这些因变量中的每一个,我们使用有关配偶的身体健康、社会人口学特征、物质使用行为、感知到的社会支持以及与军事压力相关的压力等信息进行了双变量分析和多元逻辑回归模型分析。所有参与者均获得了知情同意,包括同意将调查回复与医疗和人事记录相链接。海军卫生研究中心的机构审查委员会和管理与预算办公室批准了该研究。
配偶主要为女性(86%),本人未服过兵役(79%),是现役(86%)士兵(91%)的配偶。在为期2年的观察期内,近一半(47.6%)的配偶至少获得过一张阿片类药物处方,8.5%的配偶收到过对其健康有风险的阿片类药物处方。约7%符合接受高风险阿片类药物处方的标准,3%在3个月期间从三个以上药房获取阿片类药物,在接受任何阿片类药物的配偶中,4%既收到了长期处方也收到了高风险处方。童年不良经历、身体疼痛和缺乏社会支持与获得高风险阿片类药物处方的几率增加有关。
在为期2年的观察期内,约48%的军属使用军事卫生系统保险开具了至少一张阿片类药物处方。国防部已采取措施尽量减少高风险阿片类药物处方,包括在2017年通过处方指南、建立管制药物管理分析报告工具、设立疼痛管理教育和培训项目等。随着减少有不良事件风险的军人及其配偶数量可能有效地减少阿片类药物的滥用,并改善军属的整体健康和安全,从而提高美国武装部队的战斗力,这些努力应继续扩大。